Tetra Bio Pharma Inc (TBP)

0.14
-0.01(-6.45%)
  • Volume:
    335,500
  • Bid/Ask:
    0.14/0.15
  • Day's Range:
    0.15 - 0.16
  • Type:Equity
  • Market:Canada
  • ISIN:CA88166Y1007
  • CUSIP:88166Y100

TBP Overview

Prev. Close
0.16
Day's Range
0.15-0.16
Revenue
-
Open
0.16
52 wk Range
0.14-0.52
EPS
-0.09
Volume
335,500
Market Cap
58.24M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
124,895
P/E Ratio
-
Beta
2
1-Year Change
-30%
Shares Outstanding
401,667,409
Next Earnings Date
-
What is your sentiment on Tetra Bio Pharma Inc?
or
Market is currently closed. Voting is open during market hours.

Tetra Bio Pharma Inc Company Profile

Employees
31
Market
Canada

Tetra Bio-Pharma Inc., a development stage biopharmaceutical company, engages in the discovery and development of immunomodulator drugs. It develops ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; Reduvo for chemotherapy-induced nausea and vomiting; PLENITUDE to treat advanced uncontrolled cancer pain; REBORN for the treatment of breakthrough cancer pain and fibromyalgia; and SERENITY to treat cancer cachexia. The company also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. is headquartered in Orleans, Canada.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummarySellStrong SellStrong SellStrong SellStrong Sell
  • Let the good times roll
    0
    • Ya !! good news for Tetra Bio
      0
      • Yessss
        0
    • Cash flows from operating activities - continuing operations (11,612,825)
      0
      • Good News for ADRS-003: Based on the safety data, the medicinal ingredient and the sterile injectable drug product ARDS-003 are both safe for use in humans
        0
        • Big news!!!
          1
          • What is it ?
            0
        • seems like just a waiting game at this point
          1
          • i believe reports say they have partners to get it out to pharmacies in mid 2020... listened to their podcasts and it's an exciting wait
            0
        • BOOM 2nd DIN
          1
          • Back above $1 by end of Feb. EZ double on the next 60 days at this point still!
            4
            • how's your dollar per share doing
              0
            • was going to post this!
              0
          • Health canada just approved one of their OTC drug
            0
            • Buying!!!
              0
              • What makes you sure, and where are you getting out?
                0
            • In at .21 out at .37. Left 3k shares to see if it continues next week.
              0
              • Should of held. we going above $1 in no time!! glta
                0
              • good trade though! I would go buy some tbh.wt.a to have exposure for later down the line. You will thank me later
                0
            • Back above $1 by May 2020. easily. Warrants supper cheap to. buy on news!
              0
              • Looking good
                0
                • Energy drink was a terrible idea. Competing against big companies, have regulators up the ass and the product doesn't even have cbd or thc in it, just hemp sugar. These guys need to make a new product and go back to trying to dev a inflammation drug like they originally were. Saying this as someone holding enough to know what's up.
                  2
                  • The stock went down coz of the units offering?
                    0
                  • This time sure, but generally the fall from $1.10 was because of the above reasons. C levels in this company need to figure it out quick.
                    0
                  • the drink will be cross skewed into CBD and THC when the time comes. They are establishing a recognized brand prior to release. one of the few thinking ahead if you ask me. next 3 more DIN#s and a big phat Buyout from big pharma at some point. jmho
                    0
                • technically ,this company should grow in next 6 months. i think we touched the bottom and the next spoke will be upto $1 and + per share. if you had enough balls buy it at $0.62c than it's quite possibly you will get a good gains in next 6 months.
                  0
                  • technically ,this company should grow in next 6 months. i think we touched the bottom and the next spoke will be upto $1 and + per share. if you had enough balls buy it at $0.62c than it's quite possibly you will get a good gains in next 6 months.
                    0
                    • What do guys think of this company?
                      0
                      • DIN# for first smokable cannabis product in the world on prescription, plus a pile more drugs in clinical trials, this could be a gem. I just bought a pile for my 5 year retirement plan. The Next GW Pharma...
                        1
                        • This is a long term stock. They are in a Medical R&D mode right, not growth. They will boom, but not for some time. This stock you buy and forget about it until they spike.
                          2
                          • This is a long term stock. They are in a Medical R&D mode right, not growth. They will boom, but not for some time. This stock you buy and forget about it until they spike.
                            0
                            • short attack!
                              0
                              • anyone watching this stock
                                0
                                • http://tetrabiopharma.com/investors/press-releases/press-release-details/2018/Tetra-Bio-Pharma-Accelerates-itsEuropean-Drug-Registration-Activities/default.aspx
                                  0
                                  • http://tetrabiopharma.com/investors/press-releases/press-release-details/2018/Tetra-Bio-Pharma-Accelerates-itsEuropean-Drug-Registration-Activities/default.aspx
                                    0
                                    • http://tetrabiopharma.com/investors/press-releases/press-release-details/2018/Tetra-Bio-Pharma-Announces-Initiation-of-Coverage-by-Paradigm-Capital/default.aspx
                                      0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.